September 23, 2021 Comments Off on New patent for Novartis drug MAYZENT Posted in: Patent Added Annual Drug Patent Expirations for MAYZENT Mayzent is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting…
The post New patent for Novartis drug MAYZENT appeared first on DrugPaten…
September 23, 2021 Comments Off on New patent for Vifor Pharma drug VELTASSA Posted in: Patent Added Annual Drug Patent Expirations for VELTASSA Veltassa is a drug marketed by Vifor Pharma and is included in one NDA. It is available from one supplier. There are twelve patents…
The post New patent for Vifor Pharma drug VELTASSA appeared first on DrugPa…